Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FP187 in mild to moderate psoriatic arthritis
NCT02475304Phase 2Withdrawn
- Sponsor
- Skåne University Hospital
- Start
- May 2015
- Primary completion
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of FP187-V2B in psoriatic arthritis (PsA), sponsored by Skåne University Hospital. Planned start May 2015; status: withdrawn.
02
Drugs
FP187-V2B
03
Conditions
psoriatic arthritis (PsA)
Beyond the preview
Go deeper on NCT02475304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02475304.